Answers are grounded in this paper and cite their sources.
The commercial availability of anamorelin, Japan's first therapeutic agent for cancer cachexia in 2021, led to an investigation into its prescription patterns at Toyama University Hospital.
No takes yet. Share an insight, caveat, or question.
Tambo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: